SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies informs about update on trading restriction of company shares

24 Jul 2023 Evaluate

With reference to the restriction on trading of Venus' shares, Venus Remedies has informed that as per the revised Surveillance Action, now trading is permitted on all trading days with +/-2% price band under Periodic Call Auction. Further, the shortlisting of securities under Enhanced Surveillance Measures is purely on account of market surveillance and it should not be construed as an adverse action against the company.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×